Review Test Submission: Week 2 – Quiz NURS 6521, 2018-With Detailed Response Feedback From Professor

These drugs have a potential for abuse, but the potential is lower than for drugs on Schedule 2. These drugs contain a combination of controlled and noncontrolled substances. Use of these drugs can cause a moderate to low physiologic dependence and a higher psychological dependence. A verbal order can be given to the pharmacy and the prescription can be refilled up to five times within 6 months. Examples include certain narcotics (codeine) and nonbarbiturate sedatives. This is scheduled drug Question 2 1 out of 1 points A 46-year-old white American has been prescribed a drug that binds to acid glycoproteins. The nurse understands that white Americans usually receive Response Feedback: White Americans have been found to have more acid glycoproteins than other ethnic groups. Therefore, when they take drugs that bind to these proteins, they have lower amounts of free or active drug than when the same dose is given to someone of another ethnic group. Since the patient is a white American, he has been prescribed a higher-than-normal dose of the drug that binds to the acid glycoprotein. Question 3 1 out of 1 points A nurse working for a drug company is involved in phase III drug evaluation studies. Which of the following might the nurse be responsible for during this stage of drug development? Response Feedback: Phase III studies involve administering investigational drugs to patients in a vast clinical market who are voluntarily enrolled in double-blind studies. In phase I studies, a small number of healthy human volunteers are given the drug after blood urine and other appropriate samples are taken to monitor drug metabolism. Sometimes volunteers who have a certain disease are used in phase I instead of healthy volunteers if the drug is expected to have significant toxicity. In phase II, volunteers are given various dosages of the test compound and studied in great detail. Dosage guidelines are usually determined in this phase. Nurses are more likely to be responsible for administering the investigational drugs in phase III than in phases I and II. Use of animal testing is done in the preclinical trials and would not involve a nurse.